Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Gross Profit: 2021-2024

Historic Gross Profit for Addex Therapeutics (ADXN) over the last 4 years, with Dec 2024 value amounting to $439,184.

  • Addex Therapeutics' Gross Profit fell 36.69% to $82,945 in Q2 2025 from the same period last year, while for Jun 2025 it was -$34.5 million, marking a year-over-year decrease of 4697.33%. This contributed to the annual value of $439,184 for FY2024, which is 69.22% down from last year.
  • Per Addex Therapeutics' latest filing, its Gross Profit stood at $439,184 for FY2024, which was down 69.22% from $1.4 million recorded in FY2023.
  • In the past 5 years, Addex Therapeutics' Gross Profit registered a high of $1.4 million during FY2023, and its lowest value of -$34,526 during FY2021.
  • For the 3-year period, Addex Therapeutics' Gross Profit averaged around $1.0 million, with its median value being $1.2 million (2022).
  • As far as peak fluctuations go, Addex Therapeutics' Gross Profit soared by 3,449.39% in 2022, and later slumped by 69.22% in 2024.
  • Yearly analysis of 4 years shows Addex Therapeutics' Gross Profit stood at -$34,526 in 2021, then soared by 3,449.39% to $1.2 million in 2022, then increased by 23.41% to $1.4 million in 2023, then plummeted by 69.22% to $439,184 in 2024.